Belzid T 250mg/31.25mg Injection
Marketer
Blubell Pharma
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Belzid T 250mg/31.25mg Injection
Combiflox 250mg/31.25mg Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial growth and spread. Administration must be under medical supervision; adhere strictly to the prescribed dosage schedule. Complete the entire treatment course, even with symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and indigestion. Report worsening symptoms or allergic reactions (rash, itching, swelling, breathing difficulties) immediately. Inform your doctor of all current medications, including those for pre-existing conditions, before use. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and ample hydration are crucial for optimal recovery. Your physician may order laboratory tests to monitor treatment effectiveness.
Uses of Belzid T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Belzid T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Belzid T 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Belzid T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Belzid T 250mg/31.25mg Injection works:
Belzid T Injection (250mg Ceftazidime/31.25mg Tazobactam) combines the antibiotic Ceftazidime with the beta-lactamase inhibitor Tazobactam. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial resistance, thus bolstering Ceftazidime's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Belzid T 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Belzid T 250mg/31.25mg Injection is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, clinical data in pregnant women are scarce.
Breast feedingSAFE IF PRESCRIBED
Belzid T 250mg/31.25mg Injection poses minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, suggesting no infant harm.
DrivingUNSAFE
Administration of Belzid T 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness. Operating a vehicle is contraindicated if these effects manifest.
KidneyCAUTION
The injectable medication, Belzid T 250mg/31.25mg, requires careful administration for individuals with impaired kidney function. Dosage modifications for Belzid T 250mg/31.25mg Injection may be necessary. Physician consultation is recommended.
LiverCAUTION
The injectable medication, Belzid T 250mg/31.25mg, requires careful administration to individuals with advanced hepatic impairment. Dosage modification for Belzid T 250mg/31.25mg Injection may be necessary. Physician consultation is recommended.
What if you forget to take Belzid T 250mg/31.25mg Injection :
Should you inadvertently omit a scheduled dose of Belzid T 250mg/31.25mg Injection, seek medical advice from your physician.
Facts to Know About Belzid T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Agents against infection |
3,018 People bought this recently